AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|14|4|364-375

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.4, 2016-05, pp. : 364-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 4949-4975

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3328-3335

Bentham Science Publishers

Access to resources Recommend Favorite

From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 960-967

Bentham Science Publishers

Access to resources Recommend Favorite

Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy

By  

Current Neuropharmacology, Vol. 11, Iss. 4, 2013-07 ,pp. : 388-413

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 27, 2017-11 ,pp. : 3000-3016

Bentham Science Publishers

Access to resources Recommend Favorite